Long-lived memory B-cell responses following BCG vaccination.

Long-lived memory B-cell responses following BCG vaccination.

The role of T-cells in immunity against Mycobacterium tuberculosis (M. tuberculosis) infection has been extensively studied, however, that of B-cells still remains comparatively unexplored. In this study, we determined the presence and frequencies of mycobacteria-specific memory B-cells (MBCs) in pe...

Full description

Bibliographic Details
Main Authors:	Ismail Sebina, Jacqueline M Cliff, Steven G Smith, Sarah Nogaro, Emily L Webb, Eleanor M Riley, Hazel M Dockrell, Alison M Elliott, Julius C R Hafalla, Stephen Cose
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3519837?pdf=render

Similar Items

Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity.
by: Ismail Sebina, et al.
Published: (2014-01-01)

Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort.
by: Irene A Biraro, et al.
Published: (2014-01-01)

What Have We Learnt about BCG Vaccination in the Last 20 Years?
by: Hazel M. Dockrell, et al.
Published: (2017-09-01)

Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda
by: Lawrence Lubyayi, et al.
Published: (2020-05-01)

Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.
by: Gyaviira Nkurunungi, et al.
Published: (2012-01-01)

Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity.
by: Jiraprapa Wipasa, et al.
Published: (2011-02-01)

The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.
by: Irene Andia Biraro, et al.
Published: (2016-01-01)

The breadth, but not the magnitude, of circulating memory B cell responses to P. falciparum increases with age/exposure in an area of low transmission.
by: Sarah I Nogaro, et al.
Published: (2011-01-01)

Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax.
by: Jiraprapa Wipasa, et al.
Published: (2010-02-01)

Persistence of the immune response induced by BCG vaccination
by: Blitz Rose, et al.
Published: (2008-01-01)

BCG vaccination: a role for vitamin D?
by: Maeve K Lalor, et al.
Published: (2011-01-01)

Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria.
by: Kirsty C Newman, et al.
Published: (2006-12-01)

Analysis of multivariate longitudinal immuno-epidemiological data using a pairwise joint modelling approach
by: Lawrence Lubyayi, et al.
Published: (2021-09-01)

<it>Mycobacterium tuberculosis </it>PPD-induced immune biomarkers measurable <it>in vitro </it>following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
by: Worth Andrew, et al.
Published: (2010-07-01)

PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
by: Syeda S Hassan, et al.
Published: (2015-01-01)

BCG lymphadenopathy detected in a BCG-vaccinated infant
by: A.S. Barouni, et al.
Published: (2004-05-01)

Recombinant BCG: Innovations on an old vaccine. Scope of BCG strains and strategies to improve long lasting memory
by: Adeliane C da Costa, et al.
Published: (2014-04-01)

Working together toward vaccines and biomarkers in the real world
by: Hazel M. Dockrell
Published: (2017-07-01)

One Health - ‘joining the dots’
by: Hazel M. Dockrell
Published: (2012-06-01)

BCG OSTEITIS
by: Kh. Daneshjou, et al.
Published: (2004-02-01)

BCG OSTEITIS
by: Kh. Daneshjou, et al.
Published: (2004-05-01)

CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.
by: Zahra Hasan, et al.
Published: (2009-12-01)

BCGΔBCG1419c increased memory CD8+ T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
by: Kee Woong Kwon, et al.
Published: (2022-09-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
by: Anne Wajja, et al.
Published: (2017-05-01)

Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and “Non-BCG” Antigens to Induce Long-Term Immune Memory
by: Wei Lv, et al.
Published: (2022-04-01)

Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
by: Jacqueline M. Cliff, et al.
Published: (2019-04-01)

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial
by: Wajja, A, et al.
Published: (2023)

Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and β-glucan.
by: Rhoda Namakula, et al.
Published: (2020-01-01)

Whole Blood Profiling of Bacillus Calmette–Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation
by: Steven G. Smith, et al.
Published: (2017-06-01)

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
by: Smith, S, et al.
Published: (2010)

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
by: Satti, I, et al.
Published: (2024)

Effect of praziquantel treatment of <it>Schistosoma mansoni </it>during pregnancy on immune responses to schistosome antigens among the offspring: results of a randomised, placebo-controlled trial
by: Cose Stephen, et al.
Published: (2011-09-01)

Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
by: Julia Bitencourt, et al.
Published: (2022-01-01)

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
by: Wajja, A, et al.
Published: (2024)

Contrasting impact of rural, versus urban, living on glucose metabolism and blood pressure in Uganda [version 2; peer review: 2 approved]
by: Richard E. Sanya, et al.
Published: (2020-08-01)

BCG Aortitis, a Rare Complication of BCG Therapy
by: Joseph Haddad, et al.
Published: (2023-01-01)

Frequency of absent BCG Scar in Babies Vaccinated with BCG
by: Aqeela Sami, et al.
Published: (2023-07-01)

Osteíte por BCG Osteitis after BCG vaccination
by: André Fukunishi Yamada, et al.
Published: (2009-03-01)

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
by: Fine, P, et al.
Published: (1996)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
by: Angela M Minassian, et al.
Published: (2011-01-01)